Advertisement

Advertisement

TPST Stock Latest News

Tempest Therapeutics files to sell 8.27M shares of common stock for holders

The FlyTempest Therapeutics files to sell 8.27M shares of common stock for holders

Tempest Therapeutics, Inc. (TPST) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Tempest Therapeutics, Inc. (TPST) Q4 Earnings Cheat Sheet

3d ago

Tempest Therapeutics Announces Private Placement Financing Agreement

PremiumCompany Announcements

Tempest Therapeutics Announces Private Placement Financing Agreement

10d ago

Tempest, Cincinnati Children’s AGCTC partner for TPST-2003 registrational study

PremiumThe Fly

Tempest, Cincinnati Children’s AGCTC partner for TPST-2003 registrational study

22d ago

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data

PremiumCompany Announcements

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data

1M ago

Tempest Therapeutics announces data from REDEEM-1 Phase 1/2a trial on TPST-2003

PremiumThe FlyTempest Therapeutics announces data from REDEEM-1 Phase 1/2a trial on TPST-2003

1M ago

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline

Company Announcements

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline

2M ago

Tempest Therapeutics Overhauls Leadership and Acquires New Assets

Company Announcements

Tempest Therapeutics Overhauls Leadership and Acquires New Assets

2M ago

Tempest Therapeutics Stockholders Extend Rights Plan and Approvals

PremiumCompany Announcements

Tempest Therapeutics Stockholders Extend Rights Plan and Approvals

2M ago

Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy

PremiumRatings

Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy

2M ago

Tempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

PremiumThe Fly

Tempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

2M ago

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting

PremiumCompany Announcements

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting

3M ago

Tempest Therapeutics files to sell 1.17M shares of common stock for holders

PremiumThe FlyTempest Therapeutics files to sell 1.17M shares of common stock for holders

4M ago

Tempest Therapeutics Secures $4.25M in Direct Offering

Company Announcements

Tempest Therapeutics Secures $4.25M in Direct Offering

4M ago

Tempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering

The Fly

Tempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering

4M ago

Tempest Therpeutics trading resumes

PremiumThe Fly

Tempest Therpeutics trading resumes

4M ago

Tempest Therapeutics Announces New Leadership and Acquisition

PremiumCompany Announcements

Tempest Therapeutics Announces New Leadership and Acquisition

4M ago

Tempest Therpeutics trading halted, volatility trading pause

PremiumThe Fly

Tempest Therpeutics trading halted, volatility trading pause

4M ago

Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience

PremiumThe Fly

Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience

4M ago

Tempest Therapeutics Reports Q3 2025 Financial Results

PremiumCompany AnnouncementsTempest Therapeutics Reports Q3 2025 Financial Results

5M ago

Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year

The Fly

Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year

5M ago

TPST Earnings this Week: How Will it Perform?

Pre-Earnings

TPST Earnings this Week: How Will it Perform?

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >